US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
ヨーロッパ
EU
Orinoquia Real Estate SOCIMI SA (MLORQ) 銘柄情報

Orinoquia Real Estate SOCIMI SA (MLORQ)

1.65

0.00

(0.00%)

終了 6月6日 12:30AM

Orinoquia Real Estate SOCIMI SA (MLORQ) 銘柄情報

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

プレミアム

通貨

1.65

( - )

買値

1.65

売値

1.65

出来高

0.00

0.00 日の範囲 0.00

1.43 52 週間の範囲 1.65

時価総額

前日終値

1.65

始値

-

時刻

最終取引時間

財務取引量

-

VWAP

-

平均取引量 (3 か月)

3,250 €

発行済株式数

12,843,000

配当利回り

PER

-

1 株当たり利益 (EPS)

-

歳入

2.89M

純利益

2.56M

Orinoquia Real Estate Socimi, S.A. operates as a real estate investment company. The company invests in apartment buildings. It has a portfolio of 4 buildings that include 73 apartments, 3 commercial units, and 5 parking spaces in Spain. The company was incorporated in 2017 and is based in Madrid, S... Orinoquia Real Estate Socimi, S.A. operates as a real estate investment company. The company invests in apartment buildings. It has a portfolio of 4 buildings that include 73 apartments, 3 commercial units, and 5 parking spaces in Spain. The company was incorporated in 2017 and is based in Madrid, Spain. 詳細を表示

セクター

Real Estate

業界

Reits

ウェブサイト

orinoquiarealestate.com

本社

Madrid, Spain

設立

2026

Orinoquia Real Estate SOCIMI SA is listed in the Real Estate sector of the ユーロネクスト with ticker MLORQ. The last closing price for Orinoquia Real Estate SO... was 1.65 €. Over the last year, Orinoquia Real Estate SO... shares have traded in a share price range of 1.43 € to 1.65 €.

Orinoquia Real Estate SO... currently has 12,843,000 shares in issue. The market capitalisation of Orinoquia Real Estate SO... is 21.19 € million.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	1.65	1.65	1.65	0	0	DE
4	0	0	1.65	1.65	1.65	0	0	DE
12	0.13	8.55263157895	1.52	1.65	1.52	59	1.65	DE
26	0.21	14.5833333333	1.44	1.65	1.44	49	1.60889815	DE
52	0.06	3.77358490566	1.59	1.65	1.43	174	1.46375621	DE
156	0.4	32	1.25	1.65	1.25	2553	1.57097991	DE
260	0.51	44.7368421053	1.14	1.65	1.14	1630	1.56746851	DE

MLORQ - Frequently Asked Questions (FAQ)

What is the current Orinoquia Real Estate SOCIMI SA share price?

The current share price of Orinoquia Real Estate SOCIMI SA is 1.65 €

How many Orinoquia Real Estate SOCIMI SA shares are in issue?

Orinoquia Real Estate SOCIMI SA has 12,843,000 shares in issue

What is the market cap of Orinoquia Real Estate SOCIMI SA?

The market capitalisation of Orinoquia Real Estate SOCIMI SA is EUR 21.19M

What is the 1 year trading range for Orinoquia Real Estate SOCIMI SA share price?

Orinoquia Real Estate SOCIMI SA has traded in the range of 1.43 € to 1.65 € during the past year

What is the cash to sales ratio of Orinoquia Real Estate SOCIMI SA?

The cash to sales ratio of Orinoquia Real Estate SOCIMI SA is 7.33

What is the registered address of Orinoquia Real Estate SOCIMI SA?

The registered address for Orinoquia Real Estate SOCIMI SA is Calle Arturo Soria 330, 12-D, Madrid, Madrid, 28033

What is the Orinoquia Real Estate SOCIMI SA website address?

The website address for Orinoquia Real Estate SOCIMI SA is orinoquiarealestate.com

Which industry sector does Orinoquia Real Estate SOCIMI SA operate in?

Orinoquia Real Estate SOCIMI SA operates in the REITs sector

US Market News

US Market News 3分前

Robust Phase 2b Efficacy and Favorable Tolerability Support Monthly Dosing for Pfizer’s GLP-1 RA BerobenatideJune 6, 2026 9:00 AM
Business Wire Results from multiple Phase 2b dose finding studies for berobenatide (PF’3944) highlight a potential first-in

Investor082

Investor082 3分前

They are all a bunch of BS artists! They have trapped many naive retail families over the years by providing false hope and expectations.

Investor082

Investor082 5分前

See you in 2028 then! LP is likely to abandon Eden before that at some point than secure a commercial certification in 2028.

Keep a ton of dry powder. Looking forward to you bragging about averaging down in the coming weeks and months, LOL! ;)

Investor082

Investor082 8分前

In that case, forget about 2026 and 2027. Likely 2028 as well. C lab and Eden won’t certified for commercial production until 2028 at the earliest. Its more likely they will abandon Eden than secure commercial certification even in 2028. Have fun with the endless dilution in pennies! ;)

WhiteOwl

WhiteOwl 9分前

Am I missing something or does that Video say everything is experimental or just theory? I was under the impression they had perfected a workable unit? Just saying.

THE OLD OWL 🦉🦉🦉

hardlesson

hardlesson 12分前

You're one of the hardest working guys on ihub. Banging out the charts on a Saturday morning. Thanks always, and have a good weekend. :)

Investor082

Investor082 12分前

LP will be back there again in a couple years still pleading for a change (pathway act) so she can submit regulatory application to FDA in 2030, LOL!

Meanwhile outstanding shares ballooned to 5B+, LOL! ;)

WhiteOwl

WhiteOwl 13分前

Am I missing something or does that Video say everything is experimental or just theory? I was under the impression they had perfected a workable unit? Just saying.

THE OLD OWL 🦉🦉🦉

glenn1919

glenn1919 16分前

BCDA......BMGL.......BGMS......ACCL......CMND.........CGTL...........https://stockcharts.com/sc3/ui/?s=CMND&p=w&yr=1&mn=3&dy=0&id=p96837884856

Investor082

Investor082 17分前

No excuses when LP disappoints on this, OK?

I will check in on this message whenever there is a decision, LOL! ;)

WhenLambo

WhenLambo 17分前

FIFA is already on public record marketing them, what could be bigger than that? They’ll continue to put VuMe out there next week

train21

train21 18分前

DRIVEN IS BACK
so I guess we going to see 5 cents again ? well are we ?

Investor082

Investor082 19分前

Don't let LP and her toxic financiers screw you year after year, LOL! ;)

Instead invest in well known AI and tech stocks run by solid management crew.

glenn1919

glenn1919 21分前

STAK......SPHL.....SMTK......SAOR.....SNBR.......SCAG.....SPPL..................................https://stockcharts.com/sc3/ui/?s=SCAG&p=w&yr=1&mn=3&dy=0&id=p96837884856

jackinthegreen

jackinthegreen 21分前

Exactly - another round of press and hype can drive the price up a bit, but without substantial new contracts and revenue outside the consumer electronics space, it will only be a temporary bump. We’ve been here before - buying on the rumor is great, but what we need is actual profitability.

train21

train21 21分前

BOTH CEOs BLOCKED ME ON X
I MUST HAVE HIT THE NAIL ON THE HEAD
ANY CEO THAT BLOCKS QUESTIONS OF THEIR DECISIONS IS HIDING SOMETHING BIG AND BAD ???

rodman

rodman 22分前

There appears to be some life left in UEEC based upon the buying and pps increase this week.

cottonmather

cottonmather 22分前

Drey Dossier. The WH Ballroom ain't what it used to be. 17 minutes https://youtu.be/VbJ4ilDvGyc?si=DispyZYqLVQNJyms

USAFpatriot

USAFpatriot 22分前

Annual meeting 8k.

https://investorshub.advfn.com/stock-market/NASDAQ/novocure-NVCR/stock-news/98686681/form-8-k-current-report

train21

train21 23分前

$GTVH YOU ALL NEED TO FILE COMPLAINTS ON THE $OTC WEB SITE AND THE $FINRA WEB SITE
I CAN NOT JUST BE THE ONLY ONE FILING COMPLAINTS HERE ? SOME OF YOU GUYS LOST THOUSANDS $$$$$
CASEY IS A SHARE SELLING SCAMMMER AND MEDIA POSTING LIAR ......... AND THATS ALL THIS STOCK IS

HGiLS

Absolutely — let’s build the full, structured deep-dive you asked for. Below is everything:

• All Eliquis ANDA filers
• Their litigation outcomes
• Each filer’s non-infringement arguments
• Why none succeeded
• Drugs where generics did win using alternative

peafunke

peafunke 25分前

You told ‘who’ so? The fifa concerts are this coming week.

HGiLS

Yes — Eliquis (apixaban) has exactly the kind of ANDA litigation you’re asking about: cases where a generic filer challenged the Orange Book patents and argued non-infringement because their own formulation or manufacturing approach did not fall within the scope of the listed patents.

Teddytropics

Teddytropics 28分前

I will leave it up to you to decide..

I ask myself.. why is this guy so obsessed with Jason Black..?

That he wants to 'to tell on Jason Black' to all..

Where Jason Black isn't involved here anymore except for the CNNA OTC page still listing him..

Orinoquia Real Estate SO...

Overlay Shares Short Ter...

Euronext G Covivio 30042...

Intesa Sanpaolo

Desjardins International...

abrdn Bloomberg All Comm...

Argo Global Listed Infra...

Euronext Core Europe 30 ...

Alterity Therapeutics

Panther Securities

Eguana Technologies

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。